The Glow blend brings together the three most established tissue-repair peptides — GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) — in a single 70mg vial. It's the streamlined version of the healing peptide stack: collagen remodeling, blood vessel formation, and cell migration in one injection.
What separates Glow from the Klow blend is what it doesn't have — KPV. That means Glow is focused purely on structural repair and regeneration without a dedicated NF-kB anti-inflammatory layer. For skin-focused, musculoskeletal, and anti-aging protocols, that's a feature, not a limitation — fewer variables, lower cost, and GHK-Cu represents a higher proportion of each dose (71.4% vs 62.5% in Klow).
Here are 5 benefits ranked by evidence quality. For dosing protocols, see the Glow Blend Dosing Guide. For mixing instructions, see the Glow Reconstitution Guide.
How the 3 Peptides Work Together
The Glow blend covers three critical phases of tissue repair:
| Phase | Peptide | What Happens |
|---|---|---|
| 1. Vascularization | BPC-157 | New blood vessels form, growth factors increase |
| 2. Cell mobilization | TB-500 | Repair cells migrate to injury site |
| 3. Tissue remodeling | GHK-Cu | Collagen synthesis, scar remodeling, gene activation |
This isn't just additive — it's sequential. BPC-157 creates the delivery network. TB-500 uses it to transport repair cells. GHK-Cu activates the genes those cells need to rebuild organized, functional tissue.
1. Collagen Synthesis and Anti-Aging (GHK-Cu)
Evidence quality: Strong (multiple human and in vitro studies)
GHK-Cu is the dominant component at 71.4% of the Glow blend. This copper-binding tripeptide activates over 4,000 human genes involved in tissue repair, antioxidant defense, and anti-inflammatory signaling (Pickart & Margolina, 2018).
Specific skin and anti-aging effects:
- Upregulates collagen types I, III, and V plus elastin production
- Remodels scar tissue by regulating metalloproteinases (MMPs) — replacing disorganized scar collagen with organized functional tissue
- Attracts mesenchymal stem cells to damaged areas
- Activates hair follicle stem cells (Park et al., 2011)
GHK-Cu levels decline naturally from ~200 ng/mL in plasma at age 20 to ~80 ng/mL by age 60. Restoring GHK-Cu through supplementation addresses a measurable age-related deficit. In the Glow blend, it provides the long-term tissue quality improvements users notice by weeks 4-8 — smoother skin texture, reduced fine lines, stronger nails.
2. Angiogenesis and Tissue Repair (BPC-157)
Evidence quality: Strong (hundreds of animal studies)
BPC-157 initiates the healing cascade that GHK-Cu's remodeling depends on. Without new blood vessels delivering oxygen and nutrients to damaged tissue, collagen synthesis stalls.
Key effects in the Glow blend:
- Promotes new blood vessel formation via VEGF upregulation — the vascular infrastructure for all repair
- Increases EGF, FGF, and other growth factors that drive tissue rebuilding (Seiwerth et al., 2014)
- Modulates nitric oxide to improve local blood flow (Sikiric et al., 2014)
- Activates FAK-paxillin pathway in tendon fibroblasts — directly accelerating connective tissue healing
BPC-157 is why the Glow blend works for musculoskeletal repair, not just skin. Its angiogenic and growth factor effects benefit tendons, ligaments, and joints in addition to surface-level tissue.
3. Cell Migration and Wound Healing (TB-500)
Evidence quality: Moderate (animal studies)
TB-500 ensures repair cells reach their targets. Its LKKTET actin-binding sequence promotes the migration of keratinocytes, endothelial cells, and fibroblasts to injury sites (Malinda et al., 1999).
Key contributions to Glow:
- Directs repair cells to where they're needed via actin polymerization
- Anti-fibrotic effects — reduces excessive scar formation during healing
- Modulates local inflammatory cytokines (Sosne et al., 2010)
- Hair follicle stimulation — activates follicular stem cells
TB-500's anti-fibrotic action is particularly valuable alongside GHK-Cu. While GHK-Cu remodels existing scar tissue, TB-500 prevents new scars from forming during the healing process.
4. Multi-Phase Repair Synergy
Evidence quality: Theoretical (no combination studies exist)
The three peptides in Glow address different bottlenecks in repair. BPC-157 builds the blood supply infrastructure. TB-500 transports repair cells along that infrastructure. GHK-Cu activates those cells for long-term remodeling.
In standalone use, the body handles these phases sequentially. With all three present simultaneously, the entire pipeline runs in parallel — which is why blend users often report faster subjective results than single-peptide protocols.
The honest caveat: This synergy is mechanistically logical but not clinically proven. No study has tested this specific three-peptide combination.
5. Hair and Nail Improvement
Evidence quality: Low-moderate (component studies, anecdotal reports)
Two of the three Glow peptides have hair-related evidence:
- GHK-Cu activates follicular stem cells and has demonstrated hair growth effects in topical studies (Park et al., 2011)
- TB-500's parent protein Thymosin Beta-4 stimulates hair follicle growth in animal models
Users commonly report improved nail strength by weeks 4-6 and hair thickness changes by weeks 8-12. These are secondary benefits — Glow isn't designed as a hair treatment, but GHK-Cu's dominance (71.4%) means significant collagen and keratin pathway activation that benefits hair and nails alongside skin.